Purpose An original and a revised vancomycin dosing protocol for obese patients were compared with respect to attainment of target serum trough vancomycin concentrations and the occurrence of ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

Dennis Cho, the See Remarks of $TWST ($TWST), sold 144 shares of the company on 01-03-2025. We received data on the trade from a recent SEC filing. This was a sale of ...

ROBERT CHESS, a director at $TWST ($TWST), sold 709 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of ...

The PS5 disc drive shortage has continued since the launch of the PS5 Pro, with scalpers driving up prices. Both the US and UK PS Direct storefronts are still out of drives, and stock continues to ...

Twist Bioscience (TWST) shares soared 9.9% in the last trading session to close at $47.94. The move was backed by solid volume with far more shares changing hands than in a normal session.

A downtrend has been apparent in Twist Bioscience (TWST) lately. While the stock has lost 9.9% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its ...

NASDAQ TWST opened at $47.50 on Friday. Twist Bioscience has a one year low of $27.41 and a one year high of $60.90. The firm has a 50 day simple moving average of $44.94 and a 200-day simple ...